# Qiagen (QGEN) — News

QGEN · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/qgen/news

## Recent headlines

- [QOEP sets up $2B sukuk program to access intl debt capital mkt](https://www.ainvest.com/news/qoep-sets-2b-sukuk-program-access-intl-debt-capital-mkt-2610) — AInvest Wire, Oct 14, 2026
  Qatar Oil and Energy Projects (QOEP) has announced plans to launch a $2 billion sukuk issuance program to access international debt capital markets, signaling a strategic move to diversify its funding sources. The initiative aligns with broader trends in the global sukuk market, which has shown…
- [QIAGEN N.V.: Barclays raises to overweight from equal-weight; raises target price to $55 from $40](https://www.ainvest.com/news/qiagen-barclays-raises-overweight-equal-weight-raises-target-price-55-40-2610) — AInvest Wire, Oct 7, 2026
  Barclays has upgraded its rating for QIAGEN N.V. (QGEN) from equal-weight to overweight, reflecting a more favorable outlook for the life sciences tools and diagnostics company. The firm also raised its target price for the stock to $55 from $40, signaling increased confidence in QIAGEN’s growth…
- [QIAGEN N.V. - QIASTAT-DX system available in over 100 countries with 5,200 placements as of end 2025](https://www.ainvest.com/news/qiagen-qiastat-dx-system-100-countries-5-200-placements-2025-2609) — AInvest Wire, Sep 28, 2026
- [QIAGEN completes U.S. QIAstat-Dx bloodstream infection portfolio with FDA clearance of new bacteria detection panel](https://www.ainvest.com/news/qiagen-completes-qiastat-dx-bloodstream-infection-portfolio-fda-clearance-bacteria-detection-panel-2609) — AInvest Wire, Sep 28, 2026
  QIAGEN has completed its U.S. QIAstat-Dx bloodstream infection testing portfolio with the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for the QIAstat-Dx BCID GPF Plus AMR Panel, first bloodstream infection panel for the U.S. market. This panel is designed to detect 20…
- [QIAGEN launches QiaMini to automate small-batch sample preparation](https://www.ainvest.com/news/qiagen-launches-qiamini-automate-small-batch-sample-preparation-2609) — AInvest Wire, Sep 24, 2026
  QIAGEN has announced the launch of QIAmini, a new sample preparation instrument designed to automate small-batch workflows in laboratories. The device is part of the company’s broader strategy to expand its automation portfolio across different throughput segments, following the planned 2026…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).